Related Experiment Videos
Dose-intensity in ovarian carcinoma: hold, enough?
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical trials in gynecological cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007
Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics·2001
Chemotherapy for advanced ovarian cancer: overview of randomized trials.
Seminars in oncology·2000
Limited-stage ovarian carcinoma.
Seminars in oncology·2000
The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2000
CA 15-3 and c-erbB-2 presence in the saliva of women.
Clinical oral investigations·2000
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Time toxicity in patients receiving brachytherapy and hormonal therapy for recurrent prostate cancer: a cohort study.
BMJ supportive & palliative care·2026